Screening To Obviate Preterm Birth (STOP)
This study has been completed.
Sponsor:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01868308
First Posted: June 4, 2013
Last Update Posted: March 30, 2017
Collaborator:
Hologic, Inc.
Information provided by (Responsible Party):
University of Pennsylvania
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervicovaginal biomarkers associated with cervical remodeling in a prospective cohort of symptomatic women with a singleton pregnancy at high risk for preterm birth in an effort to better risk stratify this cohort.
| Condition |
|---|
| Preterm Labor Preterm Contractions Abdominal Cramping Back Pain Vaginal Pressure Vaginal Bleeding |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Screening To Obviate Preterm Birth |
Further study details as provided by University of Pennsylvania:
Primary Outcome Measures:
- Preterm birth [ Time Frame: Enrollment through delivery ]The primary outcome is preterm birth defined as delivery before 37 weeks.
Secondary Outcome Measures:
- Early preterm birth [ Time Frame: Enrollment through delivery ]The secondary outcome is "early" preterm birth defined as delivery before 34 weeks.
Biospecimen Retention: Samples With DNA
A vaginal swab will be collected during the patients clinical admission exam by a nurse.
| Enrollment: | 589 |
| Study Start Date: | January 2013 |
| Study Completion Date: | June 2015 |
| Primary Completion Date: | February 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Preterm Labor
Symptomatic women with singleton pregnancy at high risk for preterm birth between 22 - 33 6/7 weeks gestational age. We define "high risk for preterm birth" as women who present to our triage unit with complaints of preterm labor, including but not limited to preterm contractions, abdominal cramping, back pain, vaginal pressure, and vaginal bleeding.
|
Detailed Description:
Preterm Birth is a complex syndrome for which several different biologically plausible pathways have been proposed, including mechanical uterine distension, abruption, inflammation, and/or activation of the fetal hypothalamic-pituitary-axis. However, despite our knowing the complexity of this syndrome and the different pathways involved, there is a paucity of clinical studies investigating whether detection of more than one of these pathways in a single patient might enhance the identification of those at greatest risk for preterm birth. We propose investigating the predictive value of a panel of biomarkers associated with two biological plausible pathways - membrane breakdown and cervical remodeling - that must be involved in the pathogenesis of preterm birth. Specifically, we propose measuring cervical length and collecting cervicovaginal fetal fibronectin as well as a panel of novel cervicovaginal biomarkers that reflect molecular pathways involved in cervical remodeling in a prospectively collected cohort of symptomatic women with singleton fetuses at high risk for preterm birth. Through this study we hope improve risk stratification of this high risk cohort.
Eligibility
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Senior |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
All pregnant women presenting to the perinatal evaluation center at the Hospital of the University of Pennsylvania with preterm labor symptoms will be approached for the study.
Criteria
Inclusion Criteria:
- Singleton pregnancy between 22- 33 6/7 weeks of gestational age.
- Must be experiencing one ore more of the following symptoms including but not limited to preterm contractions, abdominal cramping, back pain, vaginal pressure, or light vaginal bleeding.
Exclusion Criteria:
- Women with a multi-fetal pregnancy
- Intra uterine fetal demise
- Preterm premature rupture of membranes
- Overt chorioamnionitis
Contacts and Locations
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01868308
Locations
| United States, Pennsylvania | |
| Hospital of the University of Pennsylvania | |
| Philadelphia, Pennsylvania, United States, 19104 | |
Sponsors and Collaborators
University of Pennsylvania
Hologic, Inc.
Investigators
| Principal Investigator: | Michal A Elovitz, MD | University of Pennsylvania |
More Information
| Responsible Party: | University of Pennsylvania |
| ClinicalTrials.gov Identifier: | NCT01868308 History of Changes |
| Other Study ID Numbers: |
817085 |
| First Submitted: | May 29, 2013 |
| First Posted: | June 4, 2013 |
| Last Update Posted: | March 30, 2017 |
| Last Verified: | March 2017 |
Additional relevant MeSH terms:
|
Back Pain Premature Birth Obstetric Labor, Premature Uterine Hemorrhage Pain Neurologic Manifestations Nervous System Diseases |
Signs and Symptoms Obstetric Labor Complications Pregnancy Complications Uterine Diseases Genital Diseases, Female Hemorrhage Pathologic Processes |